280 related articles for article (PubMed ID: 35403972)
1. Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies.
Cook MR; Dunleavy K
Curr Oncol Rep; 2022 Sep; 24(9):1121-1131. PubMed ID: 35403972
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
[TBL] [Abstract][Full Text] [Related]
3. The tumor microenvironment of lymphomas: Insights into the potential role and modes of actions of checkpoint inhibitors.
Menter T; Tzankov A; Dirnhofer S
Hematol Oncol; 2021 Feb; 39(1):3-10. PubMed ID: 33105031
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Immune Microenvironment in Lymphomas of B-Cell Origin: From Biology to Clinical Application.
Mulder TA; Wahlin BE; Österborg A; Palma M
Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31261914
[TBL] [Abstract][Full Text] [Related]
5. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes.
Nagpal P; Descalzi-Montoya DB; Lodhi N
Cancer Rep (Hoboken); 2021 Apr; 4(2):e1311. PubMed ID: 33103852
[TBL] [Abstract][Full Text] [Related]
6. Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities.
Liu Y; Zhou X; Wang X
J Hematol Oncol; 2021 Aug; 14(1):125. PubMed ID: 34404434
[TBL] [Abstract][Full Text] [Related]
7. The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells.
Ingravallo G; Tamma R; Opinto G; Annese T; Gaudio F; Specchia G; Perrone T; Musto P; Cazzato G; Bellitti E; Capodiferro S; Maiorano E; Ribatti D
Diagnostics (Basel); 2022 Feb; 12(3):. PubMed ID: 35328127
[TBL] [Abstract][Full Text] [Related]
8. In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy.
Marcelis L; Antoranz A; Delsupehe AM; Biesemans P; Ferreiro JF; Debackere K; Vandenberghe P; Verhoef G; Gheysens O; Cattoretti G; Bosisio FM; Sagaert X; Dierickx D; Tousseyn T
Cancer Immunol Immunother; 2020 Sep; 69(9):1751-1766. PubMed ID: 32335702
[TBL] [Abstract][Full Text] [Related]
9. Single-Cell Transcriptome Analysis Reveals Disease-Defining T-cell Subsets in the Tumor Microenvironment of Classic Hodgkin Lymphoma.
Aoki T; Chong LC; Takata K; Milne K; Hav M; Colombo A; Chavez EA; Nissen M; Wang X; Miyata-Takata T; Lam V; Viganò E; Woolcock BW; Telenius A; Li MY; Healy S; Ghesquiere C; Kos D; Goodyear T; Veldman J; Zhang AW; Kim J; Saberi S; Ding J; Farinha P; Weng AP; Savage KJ; Scott DW; Krystal G; Nelson BH; Mottok A; Merchant A; Shah SP; Steidl C
Cancer Discov; 2020 Mar; 10(3):406-421. PubMed ID: 31857391
[TBL] [Abstract][Full Text] [Related]
10. Applications of Single-Cell Omics to Dissect Tumor Microenvironment.
Guo T; Li W; Cai X
Front Genet; 2020; 11():548719. PubMed ID: 33329692
[TBL] [Abstract][Full Text] [Related]
11. [Characterization of the tumor microenvironment by highly multiplexed microscopy].
Schürch CM
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):21-24. PubMed ID: 36222923
[TBL] [Abstract][Full Text] [Related]
12. Novel insights into Hodgkin lymphoma biology by single-cell analysis.
Aoki T; Steidl C
Blood; 2023 Apr; 141(15):1791-1801. PubMed ID: 36548960
[TBL] [Abstract][Full Text] [Related]
13. The Microenvironment of Pituitary Tumors-Biological and Therapeutic Implications.
Ilie MD; Vasiljevic A; Raverot G; Bertolino P
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31640258
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the diagnostic and prognostic value of PDL1 expression in Hodgkin and B-cell lymphomas.
Menter T; Bodmer-Haecki A; Dirnhofer S; Tzankov A
Hum Pathol; 2016 Aug; 54():17-24. PubMed ID: 27045512
[TBL] [Abstract][Full Text] [Related]
15. Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.
Chakraborty S; Carnazza M; Jarboe T; DeSouza N; Li XM; Moscatello A; Geliebter J; Tiwari RK
Adv Exp Med Biol; 2021; 1350():33-66. PubMed ID: 34888843
[TBL] [Abstract][Full Text] [Related]
16. [Tumor microenvironment: promising therapeutic target].
Kawasaki Y; Akiyama T
Nihon Rinsho; 2015 Aug; 73(8):1283-7. PubMed ID: 26281679
[TBL] [Abstract][Full Text] [Related]
17. Multimodal Molecular Imaging of the Tumour Microenvironment.
Foray C; Barca C; Backhaus P; Schelhaas S; Winkeler A; Viel T; Schäfers M; Grauer O; Jacobs AH; Zinnhardt B
Adv Exp Med Biol; 2020; 1225():71-87. PubMed ID: 32030648
[TBL] [Abstract][Full Text] [Related]
18. The importance of the tumor microenvironment in the therapeutic management of cancer.
Pottier C; Wheatherspoon A; Roncarati P; Longuespée R; Herfs M; Duray A; Delvenne P; Quatresooz P
Expert Rev Anticancer Ther; 2015; 15(8):943-54. PubMed ID: 26098949
[TBL] [Abstract][Full Text] [Related]
19. Structural Biology of the Tumor Microenvironment.
Freeman JW
Adv Exp Med Biol; 2021; 1350():91-100. PubMed ID: 34888845
[TBL] [Abstract][Full Text] [Related]
20. Tumor Microenvironment and Immunotherapy-Based Approaches in Mantle Cell Lymphoma.
Saleh K; Cheminant M; Chiron D; Burroni B; Ribrag V; Sarkozy C
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
